Clover Health Investments, Corp.
CLOV
$2.26
-$0.59-20.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 93.35% | 68.65% | 77.92% | 125.71% | 73.60% |
| Total Depreciation and Amortization | 46.54% | -48.96% | -39.14% | -66.97% | 13.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.97% | 89.07% | -40.16% | -22.00% | -61.82% |
| Change in Net Operating Assets | -270.98% | 44.22% | 230.72% | -76.67% | -75.04% |
| Cash from Operations | -162.82% | 66.74% | 366.15% | -15.83% | -67.18% |
| Capital Expenditure | 58.43% | -219.32% | -64.20% | -12.15% | -77.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.35% | -101.35% | 41.55% | -91.99% | -7.69% |
| Cash from Investing | -2.78% | -101.72% | 40.28% | -92.55% | -9.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 65,800.00% | 609.68% | -91.48% | -- |
| Repurchase of Common Stock | -851.35% | -722.25% | -145.04% | -671.70% | -12.64% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -844.95% | -643.46% | -137.70% | -2,073.47% | -57.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -223.12% | 46.70% | 180.81% | -61.08% | -63.53% |